A low-power wearable substance monitoring device

Howell, Jonathan; Nag, Arunava; McKnight, Michael; Narsipur, Shreyas; Adelegan, Oluwafemi J.

doi:10.1109/vcacs.2015.7439567

Cited by 7 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Big data systems for healthcare have been established with distributed wearable sensors which enable assessment of the global elderly population globally by continuous monitoring and acquiring and analyzing data from the distributed devices [22][23]. Behavioral therapy requires continuous long-term physiological monitoring for the treatment of conditions such as drug addiction [24][25], obesity issues [26] and alcohol addiction [27]. In [24], the wearable sensors consist of a neoprene band that contains circuitry for measuring electrodermal activity (EDA), 3-axis motion, temperature and electrocardiogram (ECG).…”

Section: Introductionmentioning

confidence: 99%

Wearable Long-Term Social Sensing for Mental Wellbeing

Long

Gao

et al. 2019

IEEE Sensors J.

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Wearable Long-Term Social Sensing for Mental Wellbeing

Long

Gao

et al. 2019

IEEE Sensors J.

View full text Add to dashboard Cite

“…Early efforts aimed at developing wearable sensing devices for drugs of abuse have mainly been limited to monitoring drug-induced changes in vital signs. , These include a wristband exploiting changes in heart rate, skin temperature, and conductance to monitor drug abuse, smart footwear which integrates pressure sensor in shoes and the corresponding changes in gait to sense alcohol consumption, or a wearable sensor which uses the opioid-induced decreased heart rate for triggering antidote delivery to tackle the drug overdose . While these wearable sensors have attracted commercial attention, they do not measure the drugs directly but rely only on the monitoring of physical parameters that can be easily influenced by several nonrelated conditions (e.g., stress and anxiety) .…”

mentioning

confidence: 99%

Wearable Electrochemical Sensors for the Monitoring and Screening of Drugs

Parrilla²,

et al. 2020

View full text Add to dashboard Cite

Wearable electrochemical sensors capable of noninvasive monitoring of chemical markers represent a rapidly emerging digital-health technology. Recent advances toward wearable continuous glucose monitoring (CGM) systems have ignited tremendous interest in expanding such sensor technology to other important fields. This article reviews for the first time wearable electrochemical sensors for monitoring therapeutic drugs and drugs of abuse. This rapidly emerging class of drug-sensing wearable devices addresses the growing demand for personalized medicine, toward improved therapeutic outcomes while minimizing the side effects of drugs and the related medical expenses. Continuous, noninvasive monitoring of therapeutic drugs within bodily fluids empowers clinicians and patients to correlate the pharmacokinetic properties with optimal outcomes by realizing patient-specific dose regulation and tracking dynamic changes in pharmacokinetics behavior while assuring the medication adherence of patients. Furthermore, wearable electrochemical drug monitoring devices can also serve as powerful screening tools in the hands of law enforcement agents to combat drug trafficking and support on-site forensic investigations. The review covers various wearable form factors developed for noninvasive monitoring of therapeutic drugs in different body fluids and toward on-site screening of drugs of abuse. The future prospects of such wearable drug monitoring devices are presented with the ultimate goals of introducing accurate real-time drug monitoring protocols and autonomous closed-loop platforms toward precise dose regulation and optimal therapeutic outcomes. Finally, current unmet challenges and existing gaps are discussed for motivating future technological innovations regarding personalized therapy. The current pace of developments and the tremendous market opportunities for such wearable drug monitoring platforms are expected to drive intense future research and commercialization efforts.

show abstract